1	In	in	IN	_	19	prep	19:AM-LOC
2	a	a	DT	_	3	det	_
3	move	move	NN	_	1	pobj	_
4	to	to	TO	_	5	aux	_
5	broaden	broaden	VB	pb=broaden.01	3	infmod	_
6	its	its	PRP$	_	7	poss	_
7	presence	presence	NN	_	5	dobj	5:A1=PPT
8	in	in	IN	_	5	prep	5:AM-LOC
9	the	the	DT	_	12	det	_
10	Latin	latin	JJ	_	11	amod	_
11	American	american	JJ	_	12	amod	_
12	market	market	NN	_	8	pobj	_
13	,	,	,	_	19	punct	_
14	Abbott	abbott	NNP	_	15	nn	_
15	Labs	lab	NNPS	p2=NNP	19	nsubj	19:A0=PAG
16	(	(	-LRB-	_	15	punct	_
17	ABT	abt	NNP	p2=NN	15	appos	_
18	)	)	-RRB-	_	15	punct	_
19	announced	announce	VBD	p2=VBN|pb=announce.01	0	root	_
20	that	that	IN	_	23	complm	_
21	it	it	PRP	_	23	nsubj	23:A0=PPT;29:A0=PAG
22	has	have	VBZ	_	23	aux	_
23	entered	enter	VBN	pb=enter.01	19	ccomp	19:A1=PPT
24	into	into	IN	_	23	prep	23:A1=LOC
25	a	a	DT	_	27	det	_
26	definitive	definitive	JJ	_	27	amod	_
27	agreement	agreement	NN	_	24	pobj	_
28	to	to	TO	_	29	aux	_
29	acquire	acquire	VB	pb=acquire.01	27	infmod	_
30	Latin	latin	JJ	p2=NNP	31	amod	_
31	American	american	JJ	_	33	amod	_
32	pharmaceutical	pharmaceutical	NN	p2=JJ	33	nn	_
33	company	company	NN	_	29	dobj	29:A1=PPT
34	,	,	,	_	33	punct	_
35	CFR	cfr	NNP	_	36	nn	_
36	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	33	appos	_
37	.	.	.	_	19	punct	_

1	As	as	IN	p2=RB	12	prep	12:AM-ADV
2	per	per	IN	_	1	prep	_
3	the	the	DT	_	4	det	_
4	terms	term	NNS	_	2	pobj	_
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	7	det	_
7	agreement	agreement	NN	_	5	pobj	_
8	,	,	,	_	12	punct	_
9	Abbott	abbott	NNP	_	10	nn	_
10	Labs	lab	NNPS	p2=NNP	12	nsubj	12:A0=PAG
11	will	will	MD	_	12	aux	12:AM-MOD
12	acquire	acquire	VB	pb=acquire.01	0	root	_
13	the	the	DT	_	15	det	_
14	holding	hold	VBG	pb=hold.01	15	amod	_
15	company	company	NN	_	12	dobj	14:A0=PAG;17:A0=PAG;12:A1=PPT
16	that	that	WDT	_	17	nsubj	17:R-A0
17	owns	own	VBZ	pb=own.01	15	rcmod	_
18	a	a	DT	_	21	det	_
19	73	0	CD	_	20	num	_
20	%	%	NN	_	21	nn	_
21	stake	stake	NN	_	17	dobj	17:A1=PPT
22	in	in	IN	_	21	prep	_
23	CFR	cfr	NNP	_	24	nn	_
24	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	22	pobj	_
25	.	.	.	_	12	punct	_

1	Abbott	abbott	NNP	p2=IN	2	nn	_
2	Labs	lab	NNPS	p2=NNP	5	nsubj	5:A0=PAG
3	will	will	MD	_	5	aux	5:AM-MOD
4	also	also	RB	_	5	advmod	5:AM-ADV
5	conduct	conduct	VB	pb=conduct.01	0	root	_
6	a	a	DT	_	10	det	_
7	public	public	JJ	_	9	amod	_
8	cash	cash	NN	_	9	nn	_
9	tender	tender	NN	_	10	nn	_
10	offer	offer	NN	p2=VBP	5	dobj	5:A1=PPT
11	for	for	IN	_	10	prep	_
12	all	all	DT	_	11	pobj	_
13	of	of	IN	_	12	prep	_
14	the	the	DT	_	16	det	_
15	outstanding	outstanding	JJ	_	16	amod	_
16	shares	share	NNS	_	13	pobj	_
17	of	of	IN	_	16	prep	_
18	CFR	cfr	NNP	_	19	nn	_
19	Pharmaceuticals	pharmaceuticals	NNP	p2=NNPS	17	pobj	_
20	following	follow	VBG	_	16	prep	_
21	necessary	necessary	JJ	_	23	amod	_
22	regulatory	regulatory	JJ	_	23	amod	_
23	approvals	approval	NNS	_	20	pobj	_
24	.	.	.	_	5	punct	_

1	The	the	DT	_	4	det	_
2	total	total	JJ	_	4	amod	_
3	purchase	purchase	NN	p2=JJ	4	nn	_
4	price	price	NN	_	5	nsubj	5:A1=PPT
5	comes	come	VBZ	pb=come.01	0	root	_
6	to	to	IN	_	5	prep	5:A4=GOL
7	approximately	approximately	RB	_	10	advmod	_
8	$	$	$	_	10	quantmod	_
9	2.9	0	CD	_	10	number	_
10	billion	#crd#	CD	_	6	pobj	11:A0=PAG
11	assuming	assume	VBG	pb=assume.02	10	partmod	_
12	all	all	DT	p2=RB	16	det	_
13	publicly	publicly	RB	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	held	hold	VBN	p2=JJ	16	amod	_
16	shares	share	NNS	_	18	nsubjpass	18:A1=PPT
17	are	be	VBP	_	18	auxpass	_
18	tendered	tender	VBN	pb=tender.01	11	ccomp	11:A1=PPT
19	to	to	IN	_	18	prep	18:A2=GOL
20	the	the	DT	_	21	det	_
21	offer	offer	NN	_	19	pobj	_
22	along	along	IN	p2=RP	21	prep	_
23	with	with	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	assumption	assumption	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	net	net	JJ	_	28	amod	_
28	debt	debt	NN	_	26	pobj	_
29	of	of	IN	_	28	prep	_
30	approximately	approximately	RB	_	33	advmod	_
31	$	$	$	_	33	quantmod	_
32	430	0	CD	_	33	number	_
33	million	#crd#	CD	_	29	pobj	_
34	.	.	.	_	5	punct	_

1	The	the	DT	_	2	det	_
2	transaction	transaction	NN	_	4	nsubjpass	4:A1=PPT;6:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	expected	expect	VBN	pb=expect.01	0	root	_
5	to	to	TO	_	6	aux	_
6	close	close	VB	pb=close.03	4	xcomp	4:C-A1
7	by	by	IN	_	6	prep	6:AM-TMP
8	the	the	DT	_	10	det	_
9	third	#ord#	JJ	_	10	amod	_
10	quarter	quarter	NN	_	7	pobj	_
11	of	of	IN	_	10	prep	_
12	2014	0	CD	_	11	pobj	_
13	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	acquisition	acquisition	NN	_	4	nsubjpass	6:A0=PAG;4:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	expected	expect	VBN	pb=expect.01	0	root	_
5	to	to	TO	_	6	aux	_
6	add	add	VB	pb=add.02	4	xcomp	4:C-A1
7	approximately	approximately	RB	_	10	advmod	_
8	$	$	$	_	10	quantmod	_
9	900	0	CD	_	10	number	_
10	million	#crd#	CD	_	6	dobj	6:A1=PPT
11	to	to	TO	p2=IN	6	prep	6:A2=PPT
12	Abbott	abbott	NNP	p2=VB	13	nn	_
13	Labs	lab	NNPS	p2=NNP	16	poss	_
14	'	'	POS	_	13	possessive	_
15	top	top	JJ	p2=NN	16	amod	_
16	line	line	NN	_	11	pobj	_
17	in	in	IN	_	6	prep	6:AM-TMP
18	the	the	DT	_	23	det	_
19	first	#ord#	JJ	_	23	amod	_
20	full	full	JJ	_	21	amod	_
21	year	year	NN	_	23	nn	_
22	post	post	NN	p2=FW	23	nn	_
23	acquisition	acquisition	NN	_	17	pobj	_
24	(	(	-LRB-	_	23	punct	_
25	2015	0	CD	_	23	appos	_
26	)	)	-RRB-	_	23	punct	_
27	.	.	.	_	4	punct	_

1	Thereafter	thereafter	RB	_	5	advmod	5:AM-DIS
2	,	,	,	_	5	punct	_
3	Abbott	abbott	NNP	_	4	nn	_
4	Labs	lab	NNPS	p2=NNP	5	nsubj	5:A0
5	expects	expect	VBZ	pb=expect.01	0	root	_
6	double	double	JJ	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	digit	digit	NN	_	9	nn	_
9	sales	sale	NNS	_	10	nn	_
10	growth	growth	NN	_	5	dobj	5:A1=PPT
11	over	over	IN	_	5	prep	5:AM-TMP
12	the	the	DT	_	15	det	_
13	next	next	JJ	_	15	amod	_
14	several	several	JJ	_	15	amod	_
15	years	year	NNS	_	11	pobj	_
16	.	.	.	_	5	punct	_

1	The	the	DT	_	2	det	_
2	transaction	transaction	NN	_	5	nsubjpass	5:A1=PPT;7:A1=PPT
3	is	be	VBZ	_	5	auxpass	_
4	also	also	RB	_	5	advmod	5:AM-DIS
5	expected	expect	VBN	pb=expect.01	0	root	_
6	to	to	TO	_	7	aux	_
7	be	be	VB	pb=be.01	5	xcomp	5:C-A1
8	accretive	accretive	JJ	p2=VBN	7	acomp	7:A2=PRD
9	to	to	IN	p2=TO	8	prep	_
10	bottom	bottom	JJ	p2=NN	11	amod	_
11	line	line	NN	_	9	pobj	_
12	in	in	IN	_	7	prep	7:AM-TMP
13	2015	0	CD	_	12	pobj	_
14	.	.	.	_	5	punct	_

1	Headquartered	headquartered	JJ	p2=VBN	7	advcl	7:AM-ADV
2	in	in	IN	_	1	prep	_
3	Chile	chile	NNP	_	2	pobj	_
4	,	,	,	_	7	punct	_
5	CFR	cfr	NNP	_	6	nn	_
6	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	7	nsubj	7:A0=PAG
7	has	have	VBZ	pb=have.03	0	root	_
8	a	a	DT	_	11	det	_
9	comprehensive	comprehensive	JJ	_	11	amod	_
10	product	product	NN	_	11	nn	_
11	portfolio	portfolio	NN	_	7	dobj	7:A1=PPT
12	with	with	IN	_	11	prep	_
13	operations	operation	NNS	_	12	pobj	_
14	in	in	IN	_	13	prep	_
15	15	0	CD	_	18	num	_
16	Latin	latin	JJ	p2=NNP	17	amod	_
17	American	american	JJ	_	18	amod	_
18	markets	market	NNS	_	14	pobj	_
19	.	.	.	_	7	punct	_

1	The	the	DT	_	2	det	_
2	acquisition	acquisition	NN	_	4	nsubjpass	4:A1=PPT;6:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	expected	expect	VBN	pb=expect.01	0	root	_
5	to	to	TO	_	6	aux	_
6	be	be	VB	pb=be.01	4	xcomp	4:C-A1
7	complementary	complementary	JJ	_	6	acomp	6:A2=PRD
8	to	to	TO	p2=IN	7	prep	_
9	Abbott	abbott	NNP	p2=VB	10	nn	_
10	Labs	lab	NNPS	p2=NNP	15	poss	_
11	'	'	POS	_	10	possessive	_
12	current	current	JJ	_	15	amod	_
13	pharmaceutical	pharmaceutical	JJ	p2=NN	15	amod	_
14	therapeutic	therapeutic	JJ	_	15	amod	_
15	areas	area	NNS	_	8	pobj	_
16	of	of	IN	_	15	prep	_
17	focus	focus	NN	p2=VB	16	pobj	_
18	including	include	VBG	_	15	prep	_
19	women	woman	NNS	_	21	poss	_
20	's	's	POS	_	19	possessive	_
21	health	health	NN	_	18	pobj	_
22	,	,	,	_	21	punct	_
23	central	central	JJ	_	25	amod	_
24	nervous	nervous	JJ	_	25	amod	_
25	system	system	NN	_	21	conj	_
26	,	,	,	_	25	punct	_
27	cardiovascular	cardiovascular	JJ	_	30	amod	_
28	and	and	CC	_	27	cc	_
29	respiratory	respiratory	JJ	_	27	conj	_
30	diseases	disease	NNS	_	25	conj	_
31	.	.	.	_	4	punct	_

1	Abbott	abbott	NNP	p2=IN	2	nn	_
2	Labs	lab	NNPS	p2=NNP	4	nsubj	4:A0=PAG
3	currently	currently	RB	_	4	advmod	4:AM-TMP
4	carries	carry	VBZ	pb=carry.01	0	root	_
5	a	a	DT	_	11	det	_
6	Zacks	zacks	NNP	p2=NNPS	7	nn	_
7	Rank	rank	NNP	_	11	npadvmod	_
8	#	#	$	p2=NN	9	nmod	_
9	3	0	CD	_	7	num	_
10	(	(	-LRB-	_	11	punct	_
11	Hold	hold	VB	p2=NNP	4	dobj	_
12	)	)	-RRB-	_	11	punct	_
13	.	.	.	_	4	punct	_

1	 	 	IN	p2=HYPH	4	mark	_
2	Emerging	emerging	JJ	p2=VBG	3	amod	_
3	markets	market	NNS	_	4	nsubj	4:A1=PPT
4	are	be	VBP	pb=be.01	0	root	_
5	key	key	JJ	_	7	amod	_
6	focus	focus	NN	p2=IN	7	nn	_
7	areas	area	NNS	_	4	attr	4:A2=PRD
8	for	for	IN	_	7	prep	_
9	Abbott	abbott	NNP	_	10	nn	_
10	Labs	lab	NNPS	p2=NNP	8	pobj	_
11	.	.	.	_	4	punct	_

1	The	the	DT	_	4	det	_
2	CFR	cfr	NNP	_	4	nn	_
3	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	4	nn	_
4	acquisition	acquisition	NN	_	6	nsubj	6:A0=PAG
5	will	will	MD	_	6	aux	6:AM-MOD
6	double	double	VB	p2=RB|pb=double.01	0	root	_
7	Abbott	abbott	NNP	_	8	nn	_
8	Labs	lab	NNPS	p2=NNP	11	poss	_
9	'	'	POS	p2=''	8	possessive	_
10	branded	brand	VBD	p2=VBN|pb=brand.01	11	amod	_
11	generics	generic	NNS	_	13	nn	10:A1
12	pharmaceutical	pharmaceutical	JJ	p2=IN	13	amod	_
13	sales	sale	NNS	_	6	dobj	6:A1=PPT
14	and	and	CC	_	13	cc	_
15	presence	presence	NN	_	13	conj	_
16	in	in	IN	_	6	prep	6:AM-TMP
17	one	#crd#	CD	_	16	pobj	_
18	of	of	IN	_	17	prep	_
19	the	the	DT	_	22	det	_
20	fast	fast	RB	p2=JJS	21	advmod	21:AM-MNR
21	growing	grow	VBG	pb=grow.01	22	amod	_
22	markets	market	NNS	_	18	pobj	21:A1=PPT
23	.	.	.	_	6	punct	_

1	As	as	IN	_	12	prep	_
2	per	per	IN	p2=FW	1	prep	_
3	IMS	ims	NNP	p2=CD	4	nn	_
4	forecasts	forecast	NNS	p2=VBZ	2	pobj	_
5	,	,	,	_	12	punct	_
6	the	the	DT	_	10	det	_
7	Latin	latin	JJ	_	8	amod	_
8	American	american	JJ	_	10	amod	_
9	pharmaceutical	pharmaceutical	JJ	p2=NN	10	amod	_
10	market	market	NN	_	12	nsubj	12:A1=PPT;20:A1=PPT
11	will	will	MD	_	12	aux	12:AM-MOD;20:AM-MOD
12	grow	grow	VB	pb=grow.01	0	root	_
13	to	to	IN	_	12	prep	12:A4=PRD
14	$	$	$	_	16	quantmod	_
15	73	0	CD	_	16	number	_
16	billion	#crd#	CD	_	13	pobj	_
17	in	in	IN	_	16	prep	_
18	2014	0	CD	_	17	pobj	_
19	and	and	CC	_	12	cc	_
20	jump	jump	VB	p2=VBP|pb=jump.01	12	conj	_
21	to	to	IN	_	20	prep	20:A4=GOL
22	$	$	$	_	24	quantmod	_
23	124	0	CD	_	24	number	_
24	billion	#crd#	CD	_	21	pobj	_
25	by	by	IN	_	20	prep	20:AM-TMP
26	2018	0	CD	_	25	pobj	_
27	.	.	.	_	12	punct	_

1	Annual	annual	JJ	p2=NN	3	amod	_
2	growth	growth	NN	_	3	nn	_
3	rates	rate	NNS	_	8	nsubjpass	8:A1=PPT;10:A1=PPT
4	in	in	IN	_	3	prep	_
5	these	these	DT	_	6	det	_
6	markets	market	NNS	_	4	pobj	_
7	are	be	VBP	_	8	auxpass	_
8	expected	expect	VBN	pb=expect.01	0	root	_
9	to	to	TO	_	10	aux	_
10	be	be	VB	pb=be.01	8	xcomp	8:C-A1
11	two	#crd#	CD	_	13	number	_
12	to	to	TO	p2=IN	13	quantmod	_
13	three	#crd#	CD	_	14	num	_
14	times	time	NNS	_	10	npadvmod	10:A2=PRD
15	that	that	IN	p2=DT	12	pobj	_
16	of	of	IN	_	15	prep	_
17	developed	develop	VBN	p2=JJ|pb=develop.01	18	amod	_
18	markets	market	NNS	_	16	pobj	17:A1=LOC
19	over	over	IN	_	18	prep	_
20	the	the	DT	_	22	det	_
21	coming	come	VBG	pb=come.01	22	amod	_
22	years	year	NNS	_	19	pobj	21:A1=PPT
23	.	.	.	_	8	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	remind	remind	VBP	p2=VB|pb=remind.01	0	root	_
3	investors	investor	NNS	_	2	dobj	2:A2=GOL
4	that	that	WDT	p2=IN	7	complm	_
5	Abbott	abbott	NNP	_	6	nn	_
6	Labs	lab	NNPS	p2=NNP	7	nsubj	7:A1=PPT
7	became	become	VBD	pb=become.01	3	rcmod	_
8	a	a	DT	_	12	det	_
9	diversified	diversified	JJ	p2=VBN	12	amod	_
10	medical	medical	JJ	_	11	amod	_
11	products	product	NNS	_	12	nn	_
12	company	company	NN	_	7	attr	13:A0=PPT;7:A2=PRD
13	focusing	focus	VBG	pb=focus.01	12	partmod	_
14	on	on	IN	_	13	prep	13:A2=PPT
15	branded	brand	VBN	p2=JJ|pb=brand.01	17	amod	_
16	generic	generic	JJ	_	17	amod	_
17	pharmaceutical	pharmaceutical	NN	p2=JJ	14	pobj	15:A1
18	,	,	,	_	17	punct	_
19	medical	medical	JJ	_	20	amod	_
20	devices	device	NNS	_	17	conj	_
21	,	,	,	_	20	punct	_
22	diagnostic	diagnostic	JJ	_	25	amod	_
23	and	and	CC	_	22	cc	_
24	nutritional	nutritional	JJ	_	22	conj	_
25	businesses	business	NNS	_	20	conj	_
26	following	follow	VBG	_	25	prep	_
27	the	the	DT	_	28	det	_
28	separation	separation	NN	_	26	pobj	_
29	of	of	IN	_	28	prep	_
30	its	its	PRP$	_	33	poss	_
31	research-based	research-based	JJ	_	33	amod	_
32	pharmaceuticals	pharmaceutical	NNS	_	33	nn	_
33	business	business	NN	_	29	pobj	_
34	into	into	IN	_	28	prep	_
35	a	a	DT	_	37	det	_
36	new	new	JJ	_	37	amod	_
37	company	company	NN	_	34	pobj	_
38	,	,	,	_	37	punct	_
39	AbbVie	abbvie	NNP	_	40	nn	_
40	Inc	inc	NNP	_	37	appos	_
41	.	.	.	_	2	punct	_

1	(	(	-LRB-	_	2	punct	_
2	ABBV	abbv	NNP	_	0	root	_
3	)	)	-RRB-	_	2	punct	_
4	,	,	,	_	2	punct	_
5	in	in	IN	_	2	prep	_
6	Jan	jan	NNP	_	5	pobj	_
7	2013	0	CD	_	6	num	_
8	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	business	business	NN	_	3	nn	_
3	environment	environment	NN	_	5	nsubj	5:A1=PPT
4	was	be	VBD	_	5	aux	_
5	challenging	challenge	VBG	pb=challenge.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-TMP
7	2013	0	CD	_	6	pobj	_
8	due	due	IN	p2=JJ	5	prep	5:AM-CAU
9	to	to	IN	_	8	pcomp	_
10	austerity	austerity	NN	_	11	nn	_
11	measures	measure	NNS	_	8	pobj	12:A1=PPT
12	undertaken	undertake	VBN	pb=undertake.01	11	partmod	_
13	by	by	IN	_	12	agent	12:A0=PAG
14	developed	develop	VBN	p2=JJ|pb=develop.01	15	amod	_
15	markets	market	NNS	_	13	pobj	14:A1=LOC
16	.	.	.	_	5	punct	_

1	Hence	hence	RB	_	16	advmod	16:AM-DIS
2	,	,	,	_	16	punct	_
3	Abbott	abbott	NNP	_	4	nn	_
4	Labs	labs	NNP	p2=NNPS	6	poss	_
5	'	'	POS	_	4	possessive	_
6	efforts	effort	NNS	_	16	nsubj	16:A0=PAG
7	to	to	TO	_	8	aux	_
8	broaden	broaden	VB	pb=broaden.01	6	infmod	_
9	its	its	PRP$	_	10	poss	_
10	presence	presence	NN	_	8	dobj	8:A1=PPT
11	in	in	IN	_	8	prep	8:AM-LOC
12	the	the	DT	_	14	det	_
13	emerging	emerge	VBG	pb=emerge.01	14	amod	_
14	markets	market	NNS	_	11	pobj	13:A0=PPT
15	will	will	MD	_	16	aux	16:AM-MOD
16	help	help	VB	pb=help.01	0	root	_
17	the	the	DT	_	18	det	_
18	company	company	NN	_	20	nsubj	20:A0=PAG;30:A0=PAG
19	to	to	TO	_	20	aux	_
20	combat	combat	VB	pb=combat.01	16	ccomp	16:A1=PPT
21	the	the	DT	_	24	det	_
22	challenging	challenge	VBG	p2=JJ|pb=challenge.01	24	amod	_
23	business	business	NN	_	24	nn	_
24	environment	environment	NN	_	20	dobj	20:A1=COM;22:A1=PPT
25	elsewhere	elsewhere	RB	_	20	advmod	_
26	in	in	IN	_	25	prep	_
27	the	the	DT	_	28	det	_
28	world	world	NN	_	26	pobj	_
29	and	and	CC	_	20	cc	_
30	maintain	maintain	VB	p2=VBP|pb=maintain.01	20	conj	_
31	top	top	JJ	_	33	hmod	_
32	-	-	HYPH	_	33	hyph	_
33	line	line	NN	_	34	nn	_
34	growth	growth	NN	_	30	dobj	30:A1=PPT
35	.	.	.	_	16	punct	_

1	Some	some	DT	_	5	det	_
2	better	well	RBR	p2=JJR	4	hmod	4:AM-MNR
3	-	-	HYPH	_	4	hyph	_
4	ranked	rank	VBN	p2=VBD|pb=rank.01	5	amod	_
5	stocks	stock	NNS	_	11	nsubj	4:A1=PPT;11:A2=GOL
6	in	in	IN	_	5	prep	_
7	the	the	DT	_	10	det	_
8	broader	broad	JJR	p2=JJ	10	amod	_
9	healthcare	healthcare	NN	_	10	nn	_
10	sector	sector	NN	_	6	pobj	_
11	include	include	VBP	pb=include.01	0	root	_
12	Allergan	allergan	NNP	_	11	dobj	11:A1=PPT
13	(	(	-LRB-	_	12	punct	_
14	AGN	agn	NNP	_	12	appos	_
15	)	)	-RRB-	_	12	punct	_
16	and	and	CC	_	12	cc	_
17	Shire	shire	NNP	_	12	conj	_
18	(	(	-LRB-	_	17	punct	_
19	SHPG	shpg	NNP	_	17	appos	_
20	)	)	-RRB-	_	17	punct	_
21	.	.	.	_	11	punct	_

1	While	while	IN	_	3	mark	_
2	Allergan	allergan	NNP	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	14	advcl	14:AM-ADV
4	a	a	DT	_	5	det	_
5	rank	rank	NN	_	3	attr	3:A2=PRD
6	#	#	$	p2=NN	7	nmod	_
7	1	0	CD	_	5	num	_
8	(	(	-LRB-	_	5	punct	_
9	Strong	strong	JJ	p2=NNP	10	amod	_
10	Buy	buy	NNP	p2=VB	5	npadvmod	_
11	)	)	-RRB-	_	5	punct	_
12	,	,	,	_	14	punct	_
13	Shire	shire	NNP	p2=NN	14	nsubj	14:A1=PPT
14	is	be	VBZ	pb=be.01	0	root	_
15	a	a	DT	_	17	det	_
16	Zacks	zacks	NNP	_	17	nn	_
17	Rank	rank	NNP	_	18	nn	_
18	#	#	$	p2=NN	14	attr	14:A2=PRD
19	2	0	CD	_	18	num	_
20	(	(	-LRB-	_	21	punct	_
21	Buy	buy	NNP	p2=VB	18	appos	_
22	)	)	-RRB-	_	21	punct	_
23	.	.	.	_	14	punct	_

